High Rates of Potentially Unnecessary Topical Antifungal Prescribing in a Large Commercial Health Insurance Claims Database, United States.

Details

• Alternative Title:
  Journal of the American Academy of Dermatology, 2025, v. 92, no. 5: High Rates of Potentially Unnecessary Topical Antifungal Prescribing in a Large Commercial Health Insurance Claims Database, United States.
• Journal Article:
  Journal of the American Academy of Dermatology
• Personal Author:
  Gold, Jeremy A. W. ; Benedict, Kaitlin ; Caplan, Avrom S. ; Lipner, Shari R. ; Smith, Dallas J.
• Description:
  Letter to the editor about severe, antifungal-resistant dermatomycoses.
• Content Notes:
  Author manuscript
• Subjects:
  • Antifungal Agents
  • Outpatients
  • Diagnostic Techniques and Procedures
  • Dermatomycoses
• Keywords:
  • antifungal resistance
  • clotrimazole-betamethasone
  • nystatin-triamcinolone
  • diagnostic testing
  • dermatomycosis
  • dermatophytosis
  • topical antifungal
  • vulvovaginal candidiasis
• Source:
  Journal of the American Academy of Dermatology, 2025, v. 92, no. 5
• DOI:
  https://doi.org/10.1016/j.jaad.2025.01.022
• ISSN:
  0190-9622 ; 1097-6787
• Pubmed ID:
  39837413
• Pubmed Central ID:
  PMC12009189
• Document Type:
  Text
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Genre:
  Journal Article
• Pages in Document:
  1119-1121 (6 pdf pages)
• Volume:
  92
• Issue:
  5
• Download URL:
  https://stacks.cdc.gov/view/cdc/261752/cdc_261752_DS1.pdf
• File Type:
  [PDF - 68.76 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:2577776e4da0f189895c708177a4d66479ea31a19498dfdd6521feea16492a0d11771523eb1b3cc24e6ea5fbb1bc09940c83e6c232a0c940be06cea899032d13